MedPath

Effect of glucose lowering drugs on some blood parameters in diabetic patients with and without retinal problems.

Phase 4
Conditions
Health Condition 1: null- Type 2 diabetes with and without retinopathy
Registration Number
CTRI/2018/05/013601
Lead Sponsor
ady Hardinge Medical College
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Type 2 diabetic patients with and without retinopathy taking treatment for atleast one year coming to Medicine and Ophthalmology Department.

Exclusion Criteria

1. Patients with uncontrolled hypertension

or recent acute cardiovascular event .

2. Pregnancy.

3. Unconscious patients/moribund patients.

4. Patients in whom fundus examination is not possible due to cataract or opacification of media.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To study the correlation of tight glycaemic control by antidiabetic medications with serum levels of MCP-1 and cathepsin-D in type 2 diabetes with and without retinopathy. <br/ ><br> <br/ ><br>Timepoint: 2 months
Secondary Outcome Measures
NameTimeMethod
1. To correlate levels of serum MCP 1 and cathepsin D with diabetic retinopathy . <br/ ><br> <br/ ><br>2. To assess the quality of life in diabetic patients with and without retinopathy by using questionnaire (WHOQOL-BREF). <br/ ><br> <br/ ><br> <br/ ><br> <br/ ><br> <br/ ><br> <br/ ><br> <br/ ><br> <br/ ><br> <br/ ><br>Timepoint: 2 months
© Copyright 2025. All Rights Reserved by MedPath